Abstract
Genetic screening to inform personal risk has only recently become an option as the cost of sequencing decreases, and our ability to interpret sequence variants improves. Studies have demonstrated that people want to learn about their genetic information and do well after learning it, but minorities are underrepresented in these studies. We surveyed Ashkenazi Jewish (AJ) and Latino/a participants in a genetic screening study to solicit choices about genetic results to return, as well as their experience with learning these results and attitudes about genetic information secrecy and security. Participants had the option to proceed through the study self-guided, and few elected to have traditional pre-test genetic education and counseling. Despite this, the majority were satisfied with the process of selecting and receiving genetic results and felt that they understood their results. Concerns about privacy and confidentiality of genetic data were minimal, though some participants expressed modest concerns about keeping any potential results secret or the confidentiality of their genetic information. Our results support the feasibility of the option of self-guided genetic screening. Additional care will need to be taken when designing population-based screening studies to meet the needs of participants who come from communities with different experiences with genetics.
Similar content being viewed by others
References
ACMG Board of Directors (2019) The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 21:1467–1468. https://doi.org/10.1038/s41436-019-0502-5
Amendola LM, Berg JS, Horowitz CR, Angelo F, Bensen JT, Biesecker BB, Biesecker LG, Cooper GM, East K, Filipski K, Fullerton SM, Gelb BD, Goddard KAB, Hailu B, Hart R, Hassmiller-Lich K, Joseph G, Kenny EE, Koenig BA, Knight S, Kwok PY, Lewis KL, McGuire A, Norton ME, Ou J, Parsons DW, Powell BC, Risch N, Robinson M, Rini C, Scollon S, Slavotinek AM, Veenstra DL, Wasserstein MP, Wilfond BS, Hindorff LA, CSER consortium, Plon SE, Jarvik GP (2018) The clinical sequencing evidence-generating research consortium: integrating genomic sequencing in diverse and medically underserved populations. Am J Hum Genet 103:319–327. https://doi.org/10.1016/j.ajhg.2018.08.007
Baskovich B, Hiraki S, Upadhyay K, Meyer P, Carmi S, Barzilai N, Darvasi A, Ozelius L, Peter I, Cho JH, Atzmon G, Clark L, Yu J, Lencz T, Pe’er I, Ostrer H, Oddoux C (2016) Expanded genetic screening panel for the Ashkenazi Jewish population. Genet Med 18:522–528. https://doi.org/10.1038/gim.2015.123
Bates M (2018) Direct-to-consumer genetic testing: is the public ready for simple, at-home DNA tests to detect disease risk? IEEE Pulse 9:11–14. https://doi.org/10.1109/MPUL.2018.2869315
Bowdin S, Gilbert A, Bedoukian E, Carew C, Adam MP, Belmont J, Bernhardt B, Biesecker L, Bjornsson HT, Blitzer M, D’Alessandro LCA, Deardorff MA, Demmer L, Elliott A, Feldman GL, Glass IA, Herman G, Hindorff L, Hisama F, Hudgins L, Innes AM, Jackson L, Jarvik G, Kim R, Korf B, Ledbetter DH, Li M, Liston E, Marshall C, Medne L, Meyn MS, Monfared N, Morton C, Mulvihill JJ, Plon SE, Rehm H, Roberts A, Shuman C, Spinner NB, Stavropoulos DJ, Valverde K, Waggoner DJ, Wilkens A, Cohn RD, Krantz ID (2016) Recommendations for the integration of genomics into clinical practice. Genet Med 18:1075–1084. https://doi.org/10.1038/gim.2016.17
Brehaut JC, O’Connor AM, Wood TJ et al (2003) Validation of a decision regret scale. Med Decis Mak 23:281–292
Brincks AM, Feaster DJ, Burns MJ, Mitrani VB (2010) The influence of health locus of control on the patient-provider relationship. Psychol Heal Med 15:720–728. https://doi.org/10.1016/j.dcn.2011.01.002.The
Bryc K, Velez C, Karafet T, Moreno-Estrada A, Reynolds A, Auton A, Hammer M, Bustamante CD, Ostrer H (2010) Genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci 107:8954–8961. https://doi.org/10.1073/pnas.0914618107
Carmi S, Hui KY, Kochav E, Liu X, Xue J, Grady F, Guha S, Upadhyay K, Ben-Avraham D, Mukherjee S, Bowen BM, Thomas T, Vijai J, Cruts M, Froyen G, Lambrechts D, Plaisance S, van Broeckhoven C, van Damme P, van Marck H, Barzilai N, Darvasi A, Offit K, Bressman S, Ozelius LJ, Peter I, Cho JH, Ostrer H, Atzmon G, Clark LN, Lencz T, Pe’er I (2014) Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins. Nat Commun 5:1–9. https://doi.org/10.1038/ncomms5835
Catchpool M, Ramchand J, Martyn M, Hare DL, James PA, Trainer AH, Knight J, Goranitis I (2019) A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy. Genet Med 21:2815–2822. https://doi.org/10.1038/s41436-019-0582-2
Catz DS, Green NS, Tobin JN, Lloyd-Puryear MA, Kyler P, Umemoto A, Cernoch J, Brown R, Wolman F (2005) Attitudes about genetics in underserved, culturally diverse populations. Commun Genet 8:161–172. https://doi.org/10.1159/000086759
Christensen KD, Roberts JS, Zikmund-Fisher BJ, Kardia S, McBride CM, Linnenbringer E, Green RC, for the REVEAL Study Group (2015) Associations between self-referral and health behavior responses to genetic risk information. Genome Med 7:10. https://doi.org/10.1186/s13073-014-0124-0
Committee on Genetics, Romero S, Biggio JR Jr et al (2017) Carrier screening for genetic conditions. Obstet Gynecol 129:e41–e55. https://doi.org/10.1097/AOG.0000000000001952
Davis DS (2004) Genetic research and communal narratives. Hast Cent Rep 34:40–49
Dorschner MO, Amendola LM, Shirts BH et al (2014) Refining the structure and content of clinical genomic reports. Am J Med Genet C Semin Med Genet 166c:85–92. https://doi.org/10.1002/ajmg.c.31395
Ekstein J, Katzenstein H (2001) The dor Yeshorim story: community-based carrier screening for Tay-Sachs disease. Adv Genet 44:297–310
Elwyn G, Gray J, Clarke A (2000) Shared decision making and non-directiveness in genetic counselling. J Med Genet 37:135–138. https://doi.org/10.1136/jmg.37.2.135
Etchegary H, Miller F, Delaat S et al (2009) Decision-making about inherited cancer risk: exploring dimensions of genetic responsibility. J Genet Couns 18:252–264. https://doi.org/10.1007/s10897-009-9218-z
Fiallos D, Applegate C, Mathews DJh, Bollinger Juli, Bergner AL, James CA (2017) Choices for return of primary and secondary genomic research results of 790 members of families with Mendelian. Eur J Hum Genet 25(5):530–537. https://doi.org/10.1038/ejhg.2017.21
Frumkin A, Raz AE, Plesser-Duvdevani M, Lieberman S (2011) "the Most important test You’ll ever take"?: attitudes toward confidential carrier matching and open individual testing among modern-religious Jews in Israel. Soc Sci Med 73:1741–1747. https://doi.org/10.1016/j.socscimed.2011.09.031
Gabai-Kapara E, Lahad A, Kaufman B, Friedman E, Segev S, Renbaum P, Beeri R, Gal M, Grinshpun-Cohen J, Djemal K, Mandell JB, Lee MK, Beller U, Catane R, King MC, Levy-Lahad E (2014) Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proc Natl Acad Sci U S A 111:14205–14210. https://doi.org/10.1073/pnas.1415979111
George S, Duran N, Norris K (2014) A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific islanders. Am J Public Health 104:e16–e31. https://doi.org/10.2105/AJPH.2013.301706
Grody WW, Thompson BH, Gregg AR, Bean LH, Monaghan KG, Schneider A, Lebo RV (2013) ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med 15:482–483. https://doi.org/10.1038/gim.2013.47
Halbert CH, Armstrong K, Gandy OH Jr, Shaker L (2006) Racial differences in trust in health care providers. Arch Intern Med 166:896–901. https://doi.org/10.1001/archinte.166.8.896
Hallam S, Nelson H, Greger V, Perreault-Micale C, Davie J, Faulkner N, Neitzel D, Casey K, Umbarger MA, Chennagiri N, Kramer AC, Porreca GJ, Kennedy CJ (2014) Validation for clinical use of, and initial clinical experience with, a novel approach to population-based carrier screening using high-throughput, next-generation DNA sequencing. J Mol Diagn 16:180–189. https://doi.org/10.1016/j.jmoldx.2013.10.006
Holtkamp KCA, van Maarle MC, Schouten MJE, Dondorp WJ, Lakeman P, Henneman L (2016) Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening? Eur J Hum Genet 24:171–177. https://doi.org/10.1038/ejhg.2015.97
Institute NHGR (2018) eMERGE Network. https://emerge.mc.vanderbilt.edu/
Kalia SS, Adelman K, Bale SJ et al (2017) Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 19:249–255. https://doi.org/10.1038/gim.2016.190
Katz JN, Lyons N, Wolff LS, Silverman J, Emrani P, Holt HL, Corbett KL, Escalante A, Losina E (2011) Medical decision-making among Hispanics and non-Hispanic whites with chronic back and knee pain: a qualitative study. BMC Musculoskelet Disord 12:78. https://doi.org/10.1186/1471-2474-12-78
Kinney AY, Gammon A, Coxworth J, Simonsen SE, Arce-Laretta M (2010) Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genet Med 12:105–115. https://doi.org/10.1097/GIM.0b013e3181c9af2d
Leib JR, Gollust SE, Hull SC, Wilfond BS (2005) Carrier screening panels for Ashkenazi Jews: is more better? Genet Med 7:185–190. https://doi.org/10.1097/01.GIM.0000156527.87525.8F
Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson I, McGuire A, Beller U, Menon U, Jacobs I (2015) Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial. J Natl Cancer Inst 107:1–11. https://doi.org/10.1093/jnci/dju379
McBride CM, Koehly LM, Sanderson SC, Kaphingst KA (2010) The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annu Rev Public Health 31:89–103. https://doi.org/10.1146/annurev.publhealth.012809.103532
Milo Rasouly H, Wynn J, Marasa M, Reingold R, Chatterjee D, Kapoor S, Piva S, Kil BH, Mu X, Alvarez M, Nestor J, Mehl K, Revah-Politi A, Lippa N, Ernst ME, Bier L, Espinal A, Haser B, Sinha A, Halim I, Fasel D, Cuneo N, Thompson JJ, Verbitsky M, Cohn EG, Goldman J, Marder K, Klitzman RL, Orjuela MA, So YS, Fedotov A, Crew KD, Kiryluk K, Appelbaum PS, Weng C, Siegel K, Gharavi AG, Chung WK (2019) Evaluation of the cost and effectiveness of diverse recruitment methods for a genetic screening study. Genet Med 21:2371–2380. https://doi.org/10.1038/s41436-019-0497-y
Nicholson LM, Schwirian PM, Groner JA (2015) Recruitment and retention strategies in clinical studies with low-income and minority populations: Progress from 2004-2014. Contemp Clin Trials 45:34–40. https://doi.org/10.1016/j.cct.2015.07.008
Nussbaum RL, Haverfield E, Esplin ED, Aradhya S (2019) Response to “The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)”. Genet Med
Ostrer H, Skorecki K (2013) The population genetics of the Jewish people. Hum Genet 132:119–127. https://doi.org/10.1007/s00439-012-1235-6
Palmer CGS, Martinez A, Fox M, Sininger Y, Grody WW, Schimmenti LA (2008) Ethnic differences in parental perceptions of genetic testing for deaf infants. J Genet Couns 17:129–138. https://doi.org/10.1007/s10897-007-9134-z
Peyser A, Singer T, Mullin C, Bristow SL, Gamma A, Onel K, Hershlag A (2018) Comparing ethnicity-based and expanded carrier screening methods at a single fertility center reveals significant differences in carrier rates and carrier couple rates. Genet Med 21:1400–1406. https://doi.org/10.1038/s41436-018-0331-y
Popejoy AB, Fullerton SM (2016) Genomics is failing on diversity. Nature 538:161–164. https://doi.org/10.1038/538161a
Raz AE, Vizner Y (2008) Carrier matching and collective socialization in community genetics: Dor Yeshorim and the reinforcement of stigma. Soc Sci Med 67:1361–1369. https://doi.org/10.1016/j.socscimed.2008.07.011
Riffin C, Pillemer K, Reid MC, Lӧckenhoff CE (2016) Decision support preferences among Hispanic and non-Hispanic white older adults with chronic musculoskeletal pain. J Gerontol Ser B 71:914–925. https://doi.org/10.1093/geronb/gbv071
Rini C, Khan CM, Moore E, Roche MI, Evans JP, Berg JS, Powell BC, Corbie-Smith G, Foreman AKM, Griesemer I, Lee K, O’Daniel JM, Henderson GE (2018) The who, what, and why of research participants’ intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study. Genet Med 20:760–769. https://doi.org/10.1038/gim.2017.176
Robinson JO, Wynn J, Biesecker B, Biesecker LG, Bernhardt B, Brothers KB, Chung WK, Christensen KD, Green RC, McGuire AL, Hart MR, Griesemer I, Patrick DL, Rini C, Veenstra D, Cronin AM, Gray SW (2019) Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven clinical sequencing exploratory research (CSER) consortium studies. Genet Med 21:2781–2790. https://doi.org/10.1038/s41436-019-0565-3
Schwei RJ, Kadunc K, Nguyen AL, Jacobs EA (2014) Impact of sociodemographic factors and previous interactions with the health care system on institutional trust in three racial/ethnic groups. Patient Educ Couns 96:333–338. https://doi.org/10.1016/j.pec.2014.06.003
Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, Eccles D, Hopper J, Li S, Southey M, Duffy S, Cuzick J, dos Santos Silva I, Miners A, Sadique Z, Yang L, Legood R, Manchanda R (2019) A cost-effectiveness analysis of multigene testing for all patients with breast cancer. JAMA Oncol 5:1718. https://doi.org/10.1001/jamaoncol.2019.3323
Sussner KM, Thompson HS, Valdimarsdottir HB, Redd WH, Jandorf L (2009) Acculturation and familiarity with, attitudes towards and beliefs about genetic testing for cancer risk within Latinas in East Harlem, New York City. J Genet Couns 18:60–71. https://doi.org/10.1007/s10897-008-9182-z
Townsend A, Adam S, Birch PH et al (2012) “I want to know what’s in Pandora’s box”: comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing. Am J Med Genet A 158a:2519–2525. https://doi.org/10.1002/ajmg.a.35554
Wang S, Ray N, Rojas W, Parra MV, Bedoya G, Gallo C, Poletti G, Mazzotti G, Hill K, Hurtado AM, Camrena B, Nicolini H, Klitz W, Barrantes R, Molina JA, Freimer NB, Bortolini MC, Salzano FM, Petzl-Erler ML, Tsuneto LT, Dipierri JE, Alfaro EL, Bailliet G, Bianchi NO, Llop E, Rothhammer F, Excoffier L, Ruiz-Linares A (2008) Geographic patterns of genome admixture in Latin American mestizos. PLoS Genet 4:1–9. https://doi.org/10.1371/journal.pgen.1000037
Wideroff L, Vadaparampil ST, Breen N et al (2003) Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Commun Genet 6:147–156. https://doi.org/10.1159/000078162
Wiesman C, Rose E, Grant A, Zimilover A, Klugman S, Schreiber-Agus N (2017) Experiences from a pilot program bringing BRCA1/2 genetic screening to theUS Ashkenazi Jewish population. Genet Med 19:529–536. https://doi.org/10.1038/gim.2016.154
Wynn J, Chung WK (2017) 23andMe paves the way for direct-to-consumer genetic health risk tests of limited clinical utility. Ann Intern Med 167:125–126. https://doi.org/10.7326/M17-1045
Wynn J, Martinez J, Duong J, Chiuzan C, Phelan JC, Fyer A, Klitzman RL, Appelbaum PS, Chung WK (2016) Research participants’ preferences for hypothetical secondary results from genomic research. J Genet Couns 26:841–851. https://doi.org/10.1007/s10897-016-0059-2
Wynn J, Lewis K, Amendola LM, Bernhardt BA, Biswas S, Joshi M, McMullen C, Scollon S (2018a) Clinical providers’ experiences with returning results from genomic sequencing: an interview study. BMC Med Genet 11:45. https://doi.org/10.1186/s12920-018-0360-z
Wynn J, Martinez J, Bulafka J, Duong J, Zhang Y, Chiuzan C, Preti J, Cremona ML, Jobanputra V, Fyer AJ, Klitzman RL, Appelbaum PS, Chung WK (2018b) Impact of receiving secondary results from genomic research: a 12-month longitudinal study. J Genet Couns 27:709–722. https://doi.org/10.1007/s10897-017-0172-x
Wynn J, Ottman R, Duong J, Wilson AL, Ahimaz P, Martinez J, Rabin R, Rosen E, Webster R, Au C, Cho MT, Egan C, Guzman E, Primiano M, Shaw JE, Sisson R, Klitzman RL, Appelbaum PS, Lichter-Konecki U, Anyane-Yeboa K, Iglesias A, Chung WK (2018c) Diagnostic exome sequencing in children: a survey of parental understanding, experience and psychological impact. Clin Genet 93:1039–1048. https://doi.org/10.1111/cge.13200
Yao R, Goetzinger KR (2016) Genetic carrier screening in the twenty-first century. Clin Lab Med 36:277–288. https://doi.org/10.1016/j.cll.2016.01.003
Zoltick ES, Linderman MD, McGinniss MA et al (2019) Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium. Genome Med 11:10. https://doi.org/10.1186/s13073-019-0619-9
Zouk H, Venner E, Lennon NJ, Muzny DM, Abrams D, Adunyah S, Albertson-Junkans L, Ames DC, Appelbaum P, Aronson S, Aufox S, Babb LJ, Balasubramanian A, Bangash H, Basford M, Bastarache L, Baxter S, Behr M, Benoit B, Bhoj E, Bielinski SJ, Bland ST, Blout C, Borthwick K, Bottinger EP, Bowser M, Brand H, Brilliant M, Brodeur W, Caraballo P, Carrell D, Carroll A, Almoguera B, Castillo L, Castro V, Chandanavelli G, Chiang T, Chisholm RL, Christensen KD, Chung W, Chute CG, City B, Cobb BL, Connolly JJ, Crane P, Crew K, Crosslin D, de Andrade M, de la Cruz J, Denson S, Denny J, DeSmet T, Dikilitas O, Friedrich C, Fullerton SM, Funke B, Gabriel S, Gainer V, Gharavi A, Glazer AM, Glessner JT, Goehringer J, Gordon AS, Graham C, Green RC, Gundelach JH, Dayal J, Hain HS, Hakonarson H, Harden MV, Harley J, Harr M, Hartzler A, Hayes MG, Hebbring S, Henrikson N, Hershey A, Hoell C, Holm I, Howell KM, Hripcsak G, Hu J, Jarvik GP, Jayaseelan JC, Jiang Y, Joo YY, Jose S, Josyula NS, Justice AE, Kalla SE, Kalra D, Karlson E, Kelly MA, Keating BJ, Kenny EE, Key D, Kiryluk K, Kitchner T, Klanderman B, Klee E, Kochan DC, Korchina V, Kottyan L, Kovar C, Kudalkar E, Kullo IJ, Lammers P, Larson EB, Lebo MS, Leduc M, Lee MT(M), Leppig KA, Leslie ND, Li R, Liang WH, Lin CF, Linder J, Lindor NM, Lingren T, Linneman JG, Liu C, Liu W, Liu X, Lynch J, Lyon H, Macbeth A, Mahadeshwar H, Mahanta L, Malin B, Manolio T, Marasa M, Marsolo K, Dinsmore MJ, Dodge S, Hynes ED, Dunlea P, Edwards TL, Eng CM, Fasel D, Fedotov A, Feng Q, Fleharty M, Foster A, Freimuth R, McGowan ML, McNally E, Meldrim J, Mentch F, Mosley J, Mukherjee S, Mullen TE, Muniz J, Murdock DR, Murphy S, Murugan M, Myers MF, Namjou B, Ni Y, Obeng AO, Onofrio RC, Taylor CO, Person TN, Peterson JF, Petukhova L, Pisieczko CJ, Pratap S, Prows CA, Puckelwartz MJ, Rahm AK, Raj R, Ralston JD, Ramaprasan A, Ramirez A, Rasmussen L, Rasmussen-Torvik L, Rasouly HM, Raychaudhuri S, Ritchie MD, Rives C, Riza B, Roden D, Rosenthal EA, Santani A, Schaid D, Scherer S, Scott S, Scrol A, Sengupta S, Shang N, Sharma H, Sharp RR, Singh R, Sleiman PMA, Slowik K, Smith JC, Smith ME, Smoller JW, Sohn S, Stanaway IB, Starren J, Stroud M, Su J, Tolwinski K, van Driest SL, Vargas SM, Varugheese M, Veenstra D, Verbitsky M, Vicente G, Wagner M, Walker K, Walunas T, Wang L, Wang Q, Wei WQ, Weiss ST, Wiesner GL, Wells Q, Weng C, White PS, Wiley KL Jr, Williams JL, Williams MS, Wilson MW, Witkowski L, Woods LA, Woolf B, Wu TJ, Wynn J, Yang Y, Yi V, Zhang G, Zhang L, Rehm HL, Gibbs RA (2019) Harmonizing clinical sequencing and interpretation for the eMERGE III network. Am J Hum Genet 105:588–605. https://doi.org/10.1016/J.AJHG.2019.07.018
Acknowledgements
We would like to thank the participants of this research study. We also thank Michelle Kowanda, Stephanie Tang, Ian Halim, and Anoushka Sinha for assistance with recruiting participants.
Funding
Research was funded by U01HG008680 (PIs: C.W., George Hripcsak, and Ali G. Gharavi) and UL1TR001873 (PI: Reilly), RM1HG007257 (PI: Appelbaum), U54 TR00187 (PI: Reilly), and 5TL1TR001875-02 (PI: Ginsberg).
Author information
Authors and Affiliations
Contributions
WKC, PSA, and CW conceived the study. JW, PSA, WKC, and CW designed the study and developed study materials. GL generated genetic results. JW, AE, and BH enrolled participants and collected data. JW, CC, and AERW analyzed data and interpreted the results. AERW and JW wrote the manuscript. All authors contributed and discussed the results and critically reviewed the manuscript.
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest. Springer Nature COI is attached.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Reed-Weston, A.E., Espinal, A., Hasar, B. et al. Choices, attitudes, and experiences of genetic screening in Latino/a and Ashkenazi Jewish individuals. J Community Genet 11, 391–403 (2020). https://doi.org/10.1007/s12687-020-00464-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-020-00464-6